{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:25:19Z","timestamp":1790522719195,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiac constructs fabricated using human induced pluripotent stem cells-derived cardiomyocytes (iPSCs-CMs) are useful for evaluating the cardiotoxicity of and cardiac response to new drugs. Previously, we fabricated scaffold-free three-dimensional (3D) tubular cardiac constructs using a bio-3D printer, which can load cardiac spheroids onto a needle array. In this study, we developed a method to measure the contractile force and to evaluate the drug response in cardiac constructs. Specifically, we measured the movement of the needle tip upon contraction of the cardiac constructs on the needle array. The contractile force and beating rate of the cardiac constructs were evaluated by analysing changes in the movement of the needle tip. To evaluate the drug response, contractile properties were measured following treatment with isoproterenol, propranolol, or blebbistatin, in which the movement of the needle tip was increased following isoproterenol treatment, but was decreased following propranolol or blebbistain, treatments. To evaluate cardiotoxicity, contraction and cell viability of the cardiac constructs were measured following doxorubicin treatment. Cell viability was found to decrease with decreasing movement of the needle tip following doxorubicin treatment. Collectively, our results show that this method can aid in evaluating the contractile force of cardiac constructs.<\/jats:p>","DOI":"10.1038\/s41598-020-65681-y","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T10:06:02Z","timestamp":1591092362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer"],"prefix":"10.1038","volume":"10","author":[{"given":"Kenichi","family":"Arai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"65681_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrd3000","volume":"9","author":"AD Ebert","year":"2010","unstructured":"Ebert, A. D. & Svendsen, C. N. Human stem cells and drug screening: opportunities and challenges. Nat. Rev. Drug Discov. 9, 367\u2013372 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"65681_CR2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"JP Hughes","year":"2011","unstructured":"Hughes, J. P., Rees, S., Kalindjian, S. B. & Philpott, K. L. Principles of early drug discovery. Br. J. Pharmacol. 162, 1239\u20131249 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"65681_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/pds.2155","volume":"20","author":"ZP Qureshi","year":"2011","unstructured":"Qureshi, Z. P., Seoane-Vazquez, E., Rodriguez-Monguio, R., Stevenson, K. B. & Szeinbach, S. L. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009. Pharmacoepidemiol. Drug Saf. 20, 772\u2013777 (2011).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"65681_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1517\/17425250902932915","volume":"5","author":"JK Gwathmey","year":"2009","unstructured":"Gwathmey, J. K., Tsaioun, K. & Hajjar, R. J. Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates. Expert Opin. Drug Metab. Toxicol. 5, 647\u2013660 (2009).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"65681_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.pharmthera.2013.03.005","volume":"138","author":"N Ferri","year":"2013","unstructured":"Ferri, N. et al. Drug attrition during pre-clinical and clinical development: Understanding and managing drug-induced cardiotoxicity. Pharmacol. Ther. 138, 470\u2013484 (2013).","journal-title":"Pharmacol. Ther."},{"key":"65681_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.vascn.2015.04.002","volume":"75","author":"K Asakura","year":"2015","unstructured":"Asakura, K. et al. Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes. J. Pharmacol. Toxicol. Methods. 75, 17\u201326 (2015).","journal-title":"J. Pharmacol. Toxicol. Methods."},{"key":"65681_CR7","doi-asserted-by":"publisher","first-page":"e0167348","DOI":"10.1371\/journal.pone.0167348","volume":"11","author":"W Yamamoto","year":"2016","unstructured":"Yamamoto, W. et al. Electrophysiological characteristics of human iPSC-derived cardiomyocytes for the assessment of drug-induced proarrhythmic potential. PLoS One. 11, e0167348 (2016).","journal-title":"PLoS One."},{"key":"65681_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tiv.2017.04.023","volume":"42","author":"J Louisse","year":"2017","unstructured":"Louisse, J. et al. Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes. Toxicol. In Vitro. 42, 182\u2013190 (2017).","journal-title":"Toxicol. In Vitro."},{"key":"65681_CR9","doi-asserted-by":"publisher","first-page":"051005","DOI":"10.1115\/1.4027145","volume":"136","author":"ML Rodriguez","year":"2014","unstructured":"Rodriguez, M. L. et al. Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts. J. Biomech. Eng. 136, 051005 (2014).","journal-title":"J. Biomech. Eng."},{"key":"65681_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrm2236","volume":"8","author":"F Pampaloni","year":"2007","unstructured":"Pampaloni, F., Reynaud, E. G. & Stelzer, E. H. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 8, 839\u2013845 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"65681_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biomaterials.2015.03.055","volume":"60","author":"AF Godier-Furn\u00e9mont","year":"2015","unstructured":"Godier-Furn\u00e9mont, A. F. et al. Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. Biomaterials. 60, 82\u201391 (2015).","journal-title":"Biomaterials."},{"key":"65681_CR12","doi-asserted-by":"crossref","unstructured":"Tandon, N., Taubman, A., Cimetta, E., Saccenti, L. & Vunjak-Novakovic, G. Portable bioreactor for perfusion and electrical stimulation of engineered cardiac tissue. Conf. Proc. IEEE Eng. Med. Biol. Soc. 6219\u20136223 (2013).","DOI":"10.1109\/EMBC.2013.6610974"},{"key":"65681_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/bmb\/ldn026","volume":"87","author":"H Jawad","year":"2008","unstructured":"Jawad, H., Lyon, A. R., Harding, S. E., Ali, N. N. & Boccaccini, A. R. Myocardial tissue engineering. Br. Med. Bull. 87, 31\u201347 (2008).","journal-title":"Br. Med. Bull."},{"key":"65681_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","volume":"556","author":"K Ronaldson-Bouchard","year":"2018","unstructured":"Ronaldson-Bouchard, K. et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature. 556, 239\u2013243 (2018).","journal-title":"Nature."},{"key":"65681_CR15","doi-asserted-by":"publisher","first-page":"6982","DOI":"10.1016\/j.biomaterials.2011.05.087","volume":"32","author":"B Nugraha","year":"2011","unstructured":"Nugraha, B. et al. Galactosylated cellulosic sponge for multi-well drug safety testing. Biomaterials. 32, 6982\u20136994 (2011).","journal-title":"Biomaterials."},{"key":"65681_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/ten.teb.2016.0322","volume":"23","author":"NI Moldovan","year":"2017","unstructured":"Moldovan, N. I., Hibino, N. & Nakayama, K. Principles of the Kenzan method for robotic cell spheroid-based three-dimensional bioprinting. Tissue Eng. Part B Rev. 23, 237\u2013244 (2017).","journal-title":"Tissue Eng. Part B Rev."},{"key":"65681_CR17","doi-asserted-by":"publisher","first-page":"e0136681","DOI":"10.1371\/journal.pone.0136681","volume":"10","author":"M Itoh","year":"2015","unstructured":"Itoh, M. et al. Scaffold-free tubular tissues created by a bio-3D printer undergo remodeling and endothelialization when implanted in rat aortae. PLoS One. 10, e0136681 (2015).","journal-title":"PLoS One."},{"key":"65681_CR18","doi-asserted-by":"publisher","first-page":"e0171448","DOI":"10.1371\/journal.pone.0171448","volume":"12","author":"H Yurie","year":"2017","unstructured":"Yurie, H. et al. The efficacy of a scaffold-free Bio 3D conduit developed from human fibroblasts on peripheral nerve regeneration in a rat sciatic nerve model. PLoS One. 12, e0171448 (2017).","journal-title":"PLoS One."},{"key":"65681_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14542-2","volume":"7","author":"Y Yanagi","year":"2017","unstructured":"Yanagi, Y. et al. In vivo and ex vivo methods of growing a liver bud through tissue connection. Sci. Rep. 7, 14085 (2017).","journal-title":"Sci. Rep."},{"key":"65681_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/icvts\/ivx444","volume":"26","author":"D Taniguchi","year":"2018","unstructured":"Taniguchi, D. et al. Scaffold-free trachea regeneration by tissue engineering with bio-3D printing. Interact. Cardiovasc. Thorac. Surg. 26, 745\u2013752 (2018).","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"65681_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.03.012","volume":"167","author":"XY Zhang","year":"2018","unstructured":"Zhang, X. Y. et al. Regeneration of diaphragm with bio-3D cellular patch. Biomaterials. 167, 1\u201314 (2018).","journal-title":"Biomaterials."},{"key":"65681_CR22","doi-asserted-by":"publisher","first-page":"e0209162","DOI":"10.1371\/journal.pone.0209162","volume":"13","author":"K Arai","year":"2018","unstructured":"Arai, K. et al. Fabrication of scaffold-free tubular cardiac constructs using a bio-3D printer. PLoS One. 13, e0209162 (2018).","journal-title":"PLoS One."},{"key":"65681_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05018-4","volume":"7","author":"CS Ong","year":"2017","unstructured":"Ong, C. S. et al. Biomaterial-free three-dimensional bioprinting of cardiac tissue using human induced pluripotent stem cell derived cardiomyocytes. Sci. Rep. 7, 4566 (2017).","journal-title":"Sci. Rep."},{"key":"65681_CR24","doi-asserted-by":"publisher","first-page":"e86492","DOI":"10.1172\/jci.insight.86492","volume":"2","author":"H Uchida","year":"2017","unstructured":"Uchida, H. et al. A xenogeneic-free system generating functional human gut organoids from pluripotent stem cells. JCI Insight. 2, e86492 (2017).","journal-title":"JCI Insight."},{"key":"65681_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCRESAHA.109.211458","volume":"107","author":"A Hansen","year":"2010","unstructured":"Hansen, A. et al. Development of a drug screening platform based on engineered heart tissue. Circ. Res. 107, 35\u201344 (2010).","journal-title":"Circ. Res."},{"key":"65681_CR26","doi-asserted-by":"publisher","first-page":"16568","DOI":"10.1073\/pnas.0908381106","volume":"106","author":"KR Stevens","year":"2009","unstructured":"Stevens, K. R. et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc. Natl. Acad. Sci. USA 106, 16568\u201316573 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"65681_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.stemcr.2016.04.011","volume":"7","author":"I Mannhardt","year":"2016","unstructured":"Mannhardt, I. et al. Human engineered heart tissue: analysis of contractile force. Stem Cell Rep. 7, 29\u201342 (2016).","journal-title":"Stem Cell Rep."},{"key":"65681_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yjmcc.2014.05.009","volume":"74","author":"MN Hirt","year":"2014","unstructured":"Hirt, M. N. et al. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J. Mol. Cell Cardiol. 74, 151\u2013161 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"65681_CR29","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1161\/CIRCRESAHA.117.312067","volume":"122","author":"L Sala","year":"2018","unstructured":"Sala, L. et al. A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo. Circ. Res. 122, e5\u2013e16 (2018).","journal-title":"Circ. Res."},{"key":"65681_CR30","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1089\/scd.2012.0490","volume":"22","author":"SD Lundy","year":"2013","unstructured":"Lundy, S. D., Zhu, W. Z., Regnier, M. & Laflamme, M. A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. 22, 1991\u20132002 (2013).","journal-title":"Stem Cells Dev."},{"key":"65681_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/CIRCRESAHA.111.251843","volume":"109","author":"M Tiburcy","year":"2011","unstructured":"Tiburcy, M. et al. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circ. Res. 109, 1105\u20131114 (2011).","journal-title":"Circ. Res."},{"key":"65681_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.biomaterials.2015.01.067","volume":"51","author":"MC Ribeiro","year":"2015","unstructured":"Ribeiro, M. C. et al. Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro\u2013correlation between contraction force and electrophysiology. Biomaterials. 51, 138\u2013150 (2015).","journal-title":"Biomaterials."},{"key":"65681_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7150\/thno.19441","volume":"8","author":"RR Besser","year":"2018","unstructured":"Besser, R. R. et al. Engineered microenvironments for maturation of stem cell derived cardiac myocytes. Theranostics. 8, 124\u2013140 (2018).","journal-title":"Theranostics."},{"key":"65681_CR34","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1016\/j.biomaterials.2013.04.026","volume":"34","author":"D Zhang","year":"2013","unstructured":"Zhang, D. et al. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials. 34, 5813\u20135820 (2013).","journal-title":"Biomaterials."},{"key":"65681_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.biomaterials.2016.09.024","volume":"111","author":"CP Jackman","year":"2016","unstructured":"Jackman, C. P., Carlson, A. L. & Bursac, N. Dynamic culture yields engineered myocardium with near-adult functional output. Biomaterials. 111, 66\u201379 (2016).","journal-title":"Biomaterials."},{"key":"65681_CR36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1089\/ten.tea.2016.0027","volume":"22","author":"AH Fong","year":"2016","unstructured":"Fong, A. H. et al. Three-dimensional adult cardiac extracellular matrix promotes maturation of human induced pluripotent stem cell-derived cardiomyocytes. Tissue Eng. Part A. 22, 1016\u20131025 (2016).","journal-title":"Tissue Eng. Part A."},{"key":"65681_CR37","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1089\/ten.tea.2011.0341","volume":"18","author":"T Boudou","year":"2012","unstructured":"Boudou, T. et al. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng. Part A. 18, 910\u2013919 (2012).","journal-title":"Tissue Eng. Part A."},{"key":"65681_CR38","doi-asserted-by":"publisher","first-page":"18129","DOI":"10.1073\/pnas.0407817101","volume":"101","author":"M Radisic","year":"2004","unstructured":"Radisic, M. et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. USA 101, 18129\u201318134 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"65681_CR39","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1161\/CIRCRESAHA.109.214429","volume":"106","author":"A Salameh","year":"2010","unstructured":"Salameh, A. et al. Cyclic mechanical stretch induces cardiomyocyte orientation and polarization of the gap junction protein connexin43. Circ. Res. 106, 1592\u20131602 (2010).","journal-title":"Circ. Res."},{"key":"65681_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pbiomolbio.2014.06.006","volume":"115","author":"S Dhein","year":"2014","unstructured":"Dhein, S. et al. Mechanical control of cell biology. Effects of cyclic mechanical stretch on cardiomyocyte cellular organization. Prog. Biophys. Mol. Biol. 115, 93\u2013102 (2014).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"65681_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/ten.tec.2010.0405","volume":"17","author":"G Kensah","year":"2011","unstructured":"Kensah, G. et al. A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation. Tissue Eng. Part C Methods. 17, 463\u2013473 (2011).","journal-title":"Tissue Eng. Part C Methods."},{"key":"65681_CR42","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/adt.2011.0396","volume":"9","author":"MK Jonsson","year":"2011","unstructured":"Jonsson, M. K., Wang, Q. D. & Becker, B. Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes. Assay Drug Dev. Technol. 9, 589\u2013599 (2011).","journal-title":"Assay Drug Dev. Technol."},{"key":"65681_CR43","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1089\/ten.tec.2014.0376","volume":"21","author":"P Beauchamp","year":"2015","unstructured":"Beauchamp, P. et al. Development and characterization of a scaffold-free 3D spheroid model of induced pluripotent stem cell-derived human cardiomyocytes. Tissue Eng. Part C Methods. 21, 852\u2013861 (2015).","journal-title":"Tissue Eng. Part C Methods."},{"key":"65681_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12012-014-9268-9","volume":"15","author":"MF Peters","year":"2015","unstructured":"Peters, M. F., Lamore, S. D., Guo, L., Scott, C. W. & Kolaja, K. L. Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line. Cardiovasc. Toxicol. 15, 127\u2013139 (2015).","journal-title":"Cardiovasc. Toxicol."},{"key":"65681_CR45","doi-asserted-by":"publisher","first-page":"pii: 93358","DOI":"10.1172\/jci.insight.93358","volume":"2","author":"T Shimauchi","year":"2017","unstructured":"Shimauchi, T. et al. TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy. JCI Insight. 2, pii: 93358 (2017).","journal-title":"JCI Insight."},{"key":"65681_CR46","doi-asserted-by":"publisher","first-page":"e68971","DOI":"10.1371\/journal.pone.0068971","volume":"8","author":"HG Jahnke","year":"2013","unstructured":"Jahnke, H. G. et al. A Novel 3D Label-free monitoring system of hES- derived cardiomyocyte clusters: a step forward to in vitro cardiotoxicity testing. PLoS One. 8, e68971 (2013).","journal-title":"PLoS One."},{"key":"65681_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/ten.tec.2017.0247","volume":"24","author":"M Takeda","year":"2018","unstructured":"Takeda, M. et al. Development of in vitro drug-induced cardiotoxicity assay by using three-dimensional cardiac tissues derived from human induced pluripotent stem cells. Tissue Eng. Part C Methods. 24, 56\u201367 (2018).","journal-title":"Tissue Eng. Part C Methods."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65681-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65681-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65681-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:41:12Z","timestamp":1670326872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65681-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65681"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65681-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"31 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Co-author K. Nakayama is a co-founder and shareholder of Cyfuse Biomedical KK and an inventor\/developer designated on the patent for the bio-3D printer. Patent title: Method for production of three-dimensional structure of cell; patent number: JP4517125. Patent title: Cell structure production device; patent number; JP5896104. The other authors have declared that no competing interests exist.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8972"}}